102 related articles for article (PubMed ID: 3412331)
1. Protein A vectorized toxins--II. Preparation and "in vitro" cytotoxic effect of protein A-ricin A chain conjugate on antibody coated human tumour cells.
Ghetie MA; Moraru I; Margineanu M; Ghetie V
Mol Immunol; 1988 May; 25(5):473-7. PubMed ID: 3412331
[TBL] [Abstract][Full Text] [Related]
2. Protein A vectorized toxins--I. Preparation and properties of protein A-ricin toxin conjugates.
Ghetie MA; Laky M; Moraru I; Ghetie V
Mol Immunol; 1986 Dec; 23(12):1373-9. PubMed ID: 3493427
[TBL] [Abstract][Full Text] [Related]
3. In vivo follow-up of the cytotoxic effect of protein A--ricin toxin conjugate, on antibody-coated target cells.
Moţa G; Mărgineanu M; Nicolae M; Bancu A; Moraru I
Immunol Lett; 1988 May; 18(1):67-72. PubMed ID: 3378832
[TBL] [Abstract][Full Text] [Related]
4. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells].
Tonevitskiĭ AG
Mol Biol (Mosk); 1985; 19(4):1034-41. PubMed ID: 4047033
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.
Ghetie MA; Richardson J; Tucker T; Jones D; Uhr JW; Vitetta ES
Cancer Res; 1991 Nov; 51(21):5876-80. PubMed ID: 1933855
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence.
O'Hare M; Brown AN; Hussain K; Gebhardt A; Watson G; Roberts LM; Vitetta ES; Thorpe PE; Lord JM
FEBS Lett; 1990 Oct; 273(1-2):200-4. PubMed ID: 2121540
[TBL] [Abstract][Full Text] [Related]
8. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
[TBL] [Abstract][Full Text] [Related]
10. Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.
Seon BK
Cancer Res; 1984 Jan; 44(1):259-64. PubMed ID: 6606488
[TBL] [Abstract][Full Text] [Related]
11. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.
Shen GL; Li JL; Ghetie MA; Ghetie V; May RD; Till M; Brown AN; Relf M; Knowles P; Uhr JW
Int J Cancer; 1988 Nov; 42(5):792-7. PubMed ID: 3263328
[TBL] [Abstract][Full Text] [Related]
13. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
14. Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.
Kishida K; Masuho Y; Saito M; Hara T; Fuji H
Cancer Immunol Immunother; 1983; 16(2):93-7. PubMed ID: 6559105
[TBL] [Abstract][Full Text] [Related]
15. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
[TBL] [Abstract][Full Text] [Related]
16. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.
Woo BH; Lee JT; Lee KC
Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157
[TBL] [Abstract][Full Text] [Related]
17. Arming alpha 2-macroglobulin with ricin A chain forms a cytotoxic conjugate that inhibits protein synthesis and kills human fibroblasts.
Martin HB; Houston LL
Biochim Biophys Acta; 1983 Feb; 762(1):128-34. PubMed ID: 6187376
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
Vallera DA; Quinones RR; Azemove SM; Soderling CC
Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750
[TBL] [Abstract][Full Text] [Related]
19. Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor.
DiStefano PS; Schweitzer JB; Taniuchi M; Johnson EM
J Cell Biol; 1985 Sep; 101(3):1107-14. PubMed ID: 2993314
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
